Summary
A thorough understanding of the clinical pharmacology of diuretic agents, particularly loop diuretics, is crucial in patients with abnormal (and those with normal) renal function. Renal insufficiency represents a pathophysiological state characterised by diuretic resistance.
Diuretic resistance is defined as a diminished pharmacological response, or diminished natriuresis, to a given dose of a diuretic. The phenomenon of diuretic resistance is demonstrated by a shift in the dose-response curve relating urinary diuretic excretion rates (dose) with sodium excretion (response). Pharmacokinetic factors underlie the diuretic resistance observed in patients with renal failure. Diminished renal blood flow and sodium filtration, accumulation of organic acids that inhibit tubular secretion of the diuretic, and inadequate cumulative sodium excretion to meet patients’ needs contribute to the diuretic-resistant state. In contrast, the pharmacological response of remnant (i.e. remaining) nephrons to diuretic agents remains intact.
The time course of delivery of diuretics to their intraluminal site of action is an independent determinant of natriuretic response. An administration regimen that continuously maintains effective rates of excretion of diuretics into the urine would be expected to cause a greater overall natriuretic effect than the same amount of diuretic administered in intermittent doses. Thus, diuretic administration strategies that take account of the altered pharmacological responses in patients with renal failure are necessary to provide effective and safe treatment. Additionally, such strategies warrant revision by the prescribing physician as renal function changes over time.
Similar content being viewed by others
References
Burg MN. Tubular chloride transport and the mode of action of some diuretics. Kidney Int 1976; 9: 189–97
Swan SK, Brater DC. Clinical pharmacology of loop diuretics and their use in chronic renal insufficiency. J Nephrol 1993; 6: 118–23
Gehr T, Sica DA. Diuretic resistance. Drug Ther 1990; 20: 95–100
Brater DC, Anderson S, Baird B, et al. Effects of piretanide in normal subjects. Clin Pharmacol Ther 1983; 34: 324–30
Brater DC, Chennavasin P, Day B, et al. Bumetanide and furo-semide. Clin Pharmacol Ther 1983; 34: 207–13
Brater DC, Leinfelder J, Anderson S. Clinical pharmacology of torasemide, a new loop diuretic. Clin Pharmacol Ther 1987; 42: 187–92
Branch RA, Cole E, North CE, et al. The influence of sodium and potassium supplements on the diuretic response to furo-semide administration in normal subjects. Br J Pharmacol 1978; 64: 285–92
Li T, Lee MG, Chiou WL. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide. J Pharmacokinet Biopharm 1986; 14: 495–507
Kirchner KA, Voelker JR, Brater DC. Intratubular albumin blunts the response to furosemide — a mechanism for diuretic resistance in the nephrotic syndrome. J Pharmacol Exp Ther 1990; 252: 1097–101
Kaojarern S, Day B, Brater DC. The time course of delivery of furosemide into urine; an independent determinant of overall response. Kidney Int 1982; 22: 69–74
Rose HJ, O’Malley K, Pruitt AW. Depression of renal clearance of furosemide in man by azotemia. Clin Pharmacol Ther 1976; 21: 141–6
Voelker JR, Cartwright-Brown D, Anderson S, et al. Comparison of loop diuretics in patients with chronic renal insufficiency. Kidney Int 1987; 32: 572–8
Brater DC. Pharmacokinetics and pharmacodynamics of furosemide in health and disease. J Cardiovasc Pharmacol 1993; 22 Suppl. 3: 52–3
Stanton BA, Kaissling B. Regulation of renal ion transport and cell growth by sodium. Am J Physiol 1989; 257: F1–10
Ellison DH. The physiologic basic of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 1991; 114: 886–94
Rudy DW, Voelker JR, Green PK, et al. Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991; 115: 360–6
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Swan, S.K. Diuretic Strategies in Patients with Renal Failure. Drugs 48, 380–385 (1994). https://doi.org/10.2165/00003495-199448030-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199448030-00005